Full AUVI-Q product line available at Walgreens at no cost to eligible commercially insured patients and those who are eligible for kaleo’s patient support programs.
Study shows majority of epinephrine auto-injectors retained over 90% concentration of epinephrine years after expiration dates, regardless of the manufacturer.
State prosecutors describe a price fixing scheme involving more than a dozen companies and as many executives responsible for sales, marketing, and pricing.
Numerous studies indicate current auto-injector configurations may be less than optimal to the task of combating anaphylaxis for a significant portion of the population.